Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703
Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
The 1st Immunotherapy of Cancer Conference (ITOC)
Reasons for combining immunotherapy with chemo to enhance anti tumour response
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology
Molecular pathways associated with immune modulation and thalidomide analogues
Dendritic cell vaccination combined with CTLA4 blockade
Immuno-biological properties of human cancer stem cells
Cost constraints affect treatment decision-making in China and Singapore - expert discussion
ecancermedicalscience Editor's Choice for January 2014
Preventing metastases by tackling exosomes
Moving breast cancer stem cell therapies to the clinic